의료용 X선 시장 예측(-2030년)

Market Overview

The Medical X-ray Market is expected to register a CAGR of 5.20% during the review period.

The elements adding to the development of market are expanding pervasiveness of ongoing infections and rising consciousness of early analysis.

The medical X-ray market is experiencing a critical lift because of the rising pervasiveness of ongoing infections. Constant infections, like cardiovascular issues, malignant growth, and respiratory circumstances, have turned into a developing concern around the world. In 2022, as per the Habitats for Infectious prevention and Anticipation (CDC) practically 60% of grown-up Americans experience the ill effects of no less than one constant sickness. Persistent illnesses like diabetes, malignant growth, and cardiovascular sickness are the main sources of death in the US, and individuals with constant sicknesses and emotional wellness conditions represent 90% of the country's USD 3.8 trillion in yearly medical services costs. This ascent in persistent sicknesses has encouraged a more noteworthy interest for cutting edge symptomatic devices, including X-ray imaging. X-ray innovation assumes a significant part in the early discovery, conclusion, and checking of these circumstances, empowering medical services experts to give convenient and exact therapy. The flexibility and viability of X-rays in catching itemized pictures of inward designs make them imperative in medical care settings.

Besides, the rising consciousness of the significance of early finding is a huge driver for the development of the medical X-ray market. Lately, there has been a developing accentuation on the early location and convenient administration of infections. The capacity of X-ray innovation to give fast and exact demonstrative imaging assumes an essential part in such manner.

Market Segmentation

Based on type, the Medical X-ray Market has been segmented into digital radiography and computed radiography. Based on component, the Market is classified into anodes, cathodes, drive components, and shieldings and filters. The mobility segment is made up of stationary and mobile.

The applications of Medical X- Ray market includes dental, cardiovascular, veterinary, orthopedics, mammography, and others. In terms of end user, the market is divided into hospitals & clinics, diagnostic imaging centers, and others.

Regional Insights

The presence of dynamic industry players and the accessibility of the items are expanding the market's development in the North America. Furthermore, increasing commonness of constant illnesses, like cardiovascular sicknesses, malignant growth, and respiratory problems among others in North America.

Europe represents the second-biggest market share because of the availability to cutting edge analysis and therapy offices, the rising improvement of cutting-edge creative X-ray innovations, like DR and Cone-Bar Registered Tomography (CBCT), and the rising weight of persistent sicknesses and the ensuing interest for cutting edge analytic imaging. Moreover, developing medical services expenditure is additionally expected to help the development of the market.

The medical X-ray market in Asia-Pacific is expected to enroll the fastest development rate owing to the developing medical services foundation, developing speculation by key part with neighborhoods producers, and developing wellbeing mindfulness among the populace. Moreover, mechanical headways in medical X-ray frameworks and an ascent in item improvement with cutting edge elements like Man-made reasoning (computer-based intelligence) combination, portion streamlining calculations, and upgraded picture handling capacities help the market development.

Major Players

Key Companies in the Medical X-ray Market are Koninklijke Philips N.V. (US), GE Healthcare (US), Aspen Imaging Healthcare (US), Fujifilm Corporation (Japan), Siemens Healthineers (Germany), Allengers Medical Systems Ltd (India), Hologic, Inc. (US), Adonis Medical System (India), and Plansee SE (US).

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

• 1.1 OVERVIEW
  • 1.1.1 MARKET SYNOPSIS

2 MARKET INTRODUCTIONS

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE
• 2.5 LIST OF ASSUMPTIONS

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA MINING
• 3.3 SECONDARY RESEARCH
• 3.4 PRIMARY RESEARCH
  • 3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • 3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5 FORECASTING TECHNIQUES
• 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.6.1 BOTTOM-UP APPROACH
  • 3.6.2 TOP-DOWN APPROACH
• 3.7 DATA TRIANGULATION
• 3.8 VALIDATION

4 MARKET DYNAMICS

• 4.1 OVERVIEW
• 4.2 DRIVERS
  • 4.2.1 INCREASING PREVALENCE OF CHRONIC DISEASES
  • 4.2.2 RISING AWARENESS OF EARLY DIAGNOSIS
  • 4.2.3 GROWING AGING POPULATION
• 4.3 RESTRAINTS
  • 4.3.1 COMPETITION FROM ALTERNATIVE IMAGING MODALITIES
• 4.4 OPPORTUNITY
  • 4.4.1 INCREASING DEMAND FOR POINT-OF-CARE IMAGING

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 R&D & DESIGNING
  • 5.1.2 MANUFACTURING
  • 5.1.3 DISTRIBUTION & SALES
  • 5.1.4 POST-SALES MONITORING
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 IMPACT OF COVID-19 ON THE GLOBAL MEDICAL X- RAY MARKET
  • 5.3.1 IMPACT ON COST OF RAW MATERIALS AND PRODUCTS
  • 5.3.2 IMPACT ON AVAILABILITY OF PRODUCTS
  • 5.3.3 IMPACT ON PRODUCTION OF MAJOR MANUFACTURERS
  • 5.3.4 IMPACT ON TRADE (IMPORT/EXPORT)

6 GLOBAL MEDICAL X-RAY MARKET, BY TYPE

• 6.1 OVERVIEW
• 6.2 DIGITAL RADIOGRAPHY
• 6.3 COMPUTED RADIOGRAPHY

7 GLOBAL MEDICAL X-RAY MARKET, BY COMPONENT

• 7.1 OVERVIEW
• 7.2 ANODES
• 7.3 CATHODES
• 7.4 DRIVE COMPONENTS
• 7.5 SHIELDINGS AND FILTERS

8 GLOBAL MEDICAL X-RAY MARKET, BY MOBILITY

• 8.1 OVERVIEW
• 8.2 STATIONARY
• 8.3 MOBILE

9 GLOBAL MEDICAL X-RAY MARKET, BY APPLICATION

• 9.1 OVERVIEW
• 9.2 DENTAL
• 9.3 CARDIOVASCULAR
• 9.4 VETERINARY
• 9.5 ORTHOPEDICS
• 9.6 MAMMOGRAPHY
• 9.7 OTHERS

10 GLOBAL MEDICAL X-RAY MARKET, BY END USER

• 10.1 OVERVIEW
• 10.2 HOSPITALS & CLINICS
• 10.3 DIAGNOSTIC IMAGING CENTERS
• 10.4 OTHERS

11 GLOBAL MEDICAL X-RAY MARKET, BY REGION

• 11.1 GLOBAL
• 11.2 NORTH AMERICA
  • 11.2.1 US
  • 11.2.2 CANADA
• 11.3 EUROPE
  • 11.3.1 GERMANY
  • 11.3.2 FRANCE
  • 11.3.3 UK
  • 11.3.4 ITALY
  • 11.3.5 SPAIN
  • 11.3.6 REST OF EUROPE
• 11.4 ASIA-PACIFIC
  • 11.4.1 CHINA
  • 11.4.2 INDIA
  • 11.4.3 JAPAN
  • 11.4.4 SOUTH KOREA
  • 11.4.5 AUSTRALIA
  • 11.4.6 REST OF ASIA-PACIFIC
• 11.5 REST OF THE WORLD
  • 11.5.1 MIDDLE EAST
  • 11.5.2 AFRICA
  • 11.5.3 LATIN AMERICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 COMPETITIVE BENCHMARKING
• 12.3 MAJOR GROWTH STRATEGY IN THE GLOBAL X-RAY MARKET
• 12.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL X-RAY MARKET
• 12.5 KEY DEVELOPMENT ANALYSIS
• 12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 12.6.1 PRODUCT/SERVICE LAUNCH/ PRODUCT APPROVAL
  • 12.6.2 PARTNERSHIP/COLLABORATION/AGREEMENT
• 12.7 FINANCIAL MATRIX
  • 12.7.1 SALES (USD BILLION), 2022
  • 12.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD BILLION), 2022

13 COMPANY PROFILE

• 13.1 GE HEALTHCARE
  • 13.1.1 COMPANY OVERVIEW
  • 13.1.2 FINANCIAL OVERVIEW
  • 13.1.3 PRODUCTS OFFERED
  • 13.1.4 KEY DEVELOPMENTS
  • 13.1.5 SWOT ANALYSIS
  • 13.1.6 KEY STRATEGIES
• 13.2 SIEMENS
  • 13.2.1 COMPANY OVERVIEW
  • 13.2.2 FINANCIAL OVERVIEW
  • 13.2.3 PRODUCTS OFFERED
  • 13.2.4 KEY DEVELOPMENTS
  • 13.2.5 KEY STRATEGIES
• 13.3 KONINKLIJKE PHILIPS N.V.
  • 13.3.1 COMPANY OVERVIEW
  • 13.3.2 FINANCIAL OVERVIEW
  • 13.3.3 PRODUCTS OFFERED
  • 13.3.4 KEY DEVELOPMENTS
  • 13.3.5 SWOT ANALYSIS
  • 13.3.6 KEY STRATEGIES
• 13.4 FUJIFILM CORPORATION
  • 13.4.1 COMPANY OVERVIEW
  • 13.4.2 FINANCIAL OVERVIEW
  • 13.4.3 PRODUCTS OFFERED
  • 13.4.4 KEY DEVELOPMENTS
  • 13.4.5 SWOT ANALYSIS
  • 13.4.6 KEY STRATEGIES
• 13.5 PLANSEE SE
  • 13.5.1 COMPANY OVERVIEW
  • 13.5.2 FINANCIAL OVERVIEW
  • 13.5.3 PRODUCTS OFFERED
  • 13.5.4 KEY DEVELOPMENTS
  • 13.5.5 KEY STRATEGIES
• 13.6 SHIMADZU CORPORATION
  • 13.6.1 COMPANY OVERVIEW
  • 13.6.2 FINANCIAL OVERVIEW
  • 13.6.3 PRODUCTS OFFERED
  • 13.6.4 KEY DEVELOPMENTS
  • 13.6.5 SWOT ANALYSIS
  • 13.6.6 KEY STRATEGIES
• 13.7 HOLOGIC, INC
  • 13.7.1 COMPANY OVERVIEWS
  • 13.7.2 FINANCIAL OVERVIEW
  • 13.7.3 PRODUCTS OFFERED
  • 13.7.4 KEY DEVELOPMENTS
  • 13.7.5 SWOT ANALYSIS
  • 13.7.6 KEY STRATEGIES
• 13.8 ALLENGERS
  • 13.8.1 COMPANY OVERVIEW
  • 13.8.2 PRODUCTS OFFERED
  • 13.8.3 KEY DEVELOPMENTS
  • 13.8.4 KEY STRATEGIES
• 13.9 ADONIS MEDICAL SYSTEMS PVT LTD
  • 13.9.1 COMPANY OVERVIEW
  • 13.9.2 FINANCIAL OVERVIEW
  • 13.9.3 PRODUCTS OFFERED
  • 13.9.4 KEY DEVELOPMENTS
  • 13.9.5 KEY STRATEGIES
• 13.10 ASPEN IMAGING HEALTHCARE
  • 13.10.1 COMPANY OVERVIEW
  • 13.10.2 FINANCIAL OVERVIEW
  • 13.10.3 PRODUCTS OFFERED
  • 13.10.4 KEY DEVELOPMENTS
  • 13.10.5 KEY STRATEGIES

14 APPENDIX

• 14.1 REFERENCES
• 14.2 RELATED REPORTS